Evidence map›Paper›PMID 38540219›Full record

ReviewBiomedicines2024

Artificial Intelligence Reporting Guidelines' Adherence in Nephrology for Improved Research and Clinical Outcomes.

Amankeldi A Salybekov, Markus Wolfien, Waldemar Hahn, Sumi Hidaka, Shuzo Kobayashi

Open access · goldAbstract readReview
In one paragraph

Review in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Amankeldi A SalybekovKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.ORCID 0000-0001-5490-9365
Markus WolfienCarl Gustav Carus Faculty of Medicine, Institute for Medical Informatics and Biometry, Technische Universität Dresden, 01317 Dresden, Germany.ORCID 0000-0002-1887-4772
Waldemar HahnCarl Gustav Carus Faculty of Medicine, Institute for Medical Informatics and Biometry, Technische Universität Dresden, 01317 Dresden, Germany.
Sumi HidakaKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.ORCID 0000-0002-1576-0868
Shuzo KobayashiKidney Disease and Transplant Center, Shonan Kamakura General Hospital, Kamakura 247-8533, Japan.
German Research Centre for Artificial Intelligence · DEShonan Kamakura General Hospital · JPAstana Medical University · KZ

Funding

This research was funded by the Science Committee of the Ministry of Science and Higher Educa-tion of the Republic of Kazakhstan grant AP14872543
6 · The paper itself

Abstract

The use of artificial intelligence (AI) in healthcare is transforming a number of medical fields, including nephrology. The integration of various AI techniques in nephrology facilitates the prediction of the early detection, diagnosis, prognosis, and treatment of kidney disease. Nevertheless, recent reports have demonstrated that the majority of published clinical AI studies lack uniform AI reporting standards, which poses significant challenges in interpreting, replicating, and translating the studies into routine clinical use. In response to these issues, worldwide initiatives have created guidelines for publishing AI-related studies that outline the minimal necessary information that researchers should include. By following standardized reporting frameworks, researchers and clinicians can ensure the reproducibility, reliability, and ethical use of AI models. This will ultimately lead to improved research outcomes, enhanced clinical decision-making, and better patient management. This review article highlights the importance of adhering to AI reporting guidelines in medical research, with a focus on nephrology and urology, and clinical practice for advancing the field and optimizing patient care.

Indexed as

AI reporting guidelinesartificial intelligenceclinical decision supportclinical trialsnephrology

Identifiers

PMID38540219
PMCPMC10968354
OpenAlexW4392545488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.